Medical Weight Loss in Florida: Telehealth Programs with Semaglutide and Tirzepatide
NuGen Medicine provides physician-supervised medical weight loss to Florida patients through HIPAA-compliant telehealth. Dr. Nima Ghadimi, a board-certified internist with over 20 years of clinical experience and training at Mayo Clinic, personally manages every treatment plan. Our Florida telehealth weight loss programs include FDA-approved GLP-1 medications such as semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound), combined with ongoing physician monitoring and nutritional guidance.
How Our Telehealth Weight Loss Program Works for Florida Patients
Florida residents can access NuGen Medicine’s physician-led weight loss program entirely through telehealth. Whether you are in Miami, Tampa, Orlando, Jacksonville, Fort Lauderdale, St. Petersburg, or any community across all 67 Florida counties, you receive the same direct physician care.
- Telehealth intake consultation: Dr. Ghadimi reviews your medical history, current medications, weight loss attempts, and health goals during a comprehensive video appointment lasting 30 to 45 minutes.
- Florida-based lab work: Baseline bloodwork is ordered through Quest Diagnostics or LabCorp locations near your Florida home. Labs include metabolic panel, thyroid function, A1C, and other markers relevant to safe weight management.
- Medication selection: After reviewing your lab results, Dr. Ghadimi determines whether semaglutide, tirzepatide, or an alternative approach is most appropriate for your situation. Every recommendation is based on your individual health data.
- Prescription fulfillment: Medications are prescribed to a Florida pharmacy near you or shipped through a specialty pharmacy directly to your door.
- Ongoing care and adjustments: Follow-up telehealth visits every two to four weeks during initial treatment, then monthly once your dosing stabilizes. Dr. Ghadimi adjusts your plan based on weight trends, side effects, and updated lab work.
GLP-1 Medications Available to Florida Patients
Semaglutide (Ozempic/Wegovy)
Semaglutide is a GLP-1 receptor agonist that reduces appetite, slows stomach emptying, and helps regulate blood sugar. Administered as a weekly subcutaneous injection, semaglutide has been shown in clinical studies to produce an average of 15% body weight loss when combined with lifestyle modifications. Dr. Ghadimi starts patients on a low dose and gradually increases it over several weeks to reduce gastrointestinal side effects.
Tirzepatide (Mounjaro/Zepbound)
Tirzepatide activates both GLP-1 and GIP receptors, producing enhanced metabolic effects compared to single-receptor medications. Clinical trials demonstrate up to 20% body weight reduction with tirzepatide. This medication may be recommended for Florida patients with a BMI of 30 or higher, or 27 or higher with obesity-related health conditions. For a side-by-side comparison of these medications, read our guide on semaglutide vs. tirzepatide.
Why Florida Patients Choose NuGen Medicine for Weight Loss
Many Florida residents seeking medical weight loss face long wait times at local clinics, impersonal telehealth platforms that rotate providers, or programs that rely on nurse practitioners rather than physicians. NuGen Medicine is different.
- Direct physician care: Dr. Ghadimi, not a PA or NP, personally manages your weight loss treatment from start to finish.
- Florida-licensed: NuGen Medicine holds an active medical license in Florida and complies with all state telehealth prescribing regulations.
- No revolving providers: You see the same physician at every appointment. Dr. Ghadimi knows your medical history, medication response, and progress without starting over each visit.
- Comprehensive health management: Weight loss care is coordinated with primary care, hormone optimization, and metabolic health monitoring, all within one practice.
- Transparent pricing: Semaglutide programs start at $350 per month. No hidden consultation fees or surprise charges.
Who Is a Candidate for Medical Weight Loss?
Dr. Ghadimi evaluates each Florida patient individually during the initial consultation. You may be a candidate for physician-supervised weight loss with GLP-1 medications if:
- Your BMI is 30 or higher
- Your BMI is 27 or higher and you have weight-related conditions such as type 2 diabetes, hypertension, sleep apnea, or high cholesterol
- Diet and exercise alone have not produced lasting results
- You do not have contraindications to GLP-1 medications (personal or family history of medullary thyroid cancer, MEN2 syndrome, or severe gastroparesis)
Medical weight loss is not a one-size-fits-all solution. Dr. Ghadimi considers your complete health profile before recommending any medication, and some patients may benefit from non-medication approaches. For more on what medical weight loss involves, see our guide on what is medical weight loss.
Florida Cities and Regions We Serve
NuGen Medicine provides telehealth weight loss consultations to patients throughout Florida, including Miami, Tampa, Orlando, Jacksonville, Fort Lauderdale, St. Petersburg, Hialeah, Tallahassee, Port St. Lucie, Cape Coral, Pembroke Pines, Hollywood, Gainesville, Coral Springs, Palm Bay, Clearwater, Lakeland, West Palm Beach, and every community across the state. Our telehealth platform ensures that distance from a major medical center is never a barrier to physician-led weight management.
What Florida Telehealth Regulations Mean for Weight Loss Patients
Florida has established clear telehealth regulations that allow licensed physicians to evaluate patients, diagnose conditions, and prescribe medications through video consultations. Dr. Ghadimi meets all Florida requirements for telehealth prescribing, including maintaining an active Florida medical license and establishing a proper physician-patient relationship before prescribing controlled or specialty medications.
For Florida patients, this means you receive the same standard of care as an in-person office visit, with the convenience of accessing your appointment from home.
Frequently Asked Questions
Can a doctor prescribe weight loss medication through telehealth in Florida?
Yes. Florida permits licensed physicians to prescribe medications, including GLP-1 weight loss drugs, through telehealth after establishing a proper physician-patient relationship. Dr. Ghadimi is licensed in Florida and conducts a comprehensive video evaluation before prescribing any weight loss medication.
What does semaglutide treatment cost in Florida through NuGen Medicine?
Semaglutide programs at NuGen Medicine start at $350 per month, which includes physician consultations, medication, and ongoing monitoring. Some insurance plans may cover portions of the treatment. Dr. Ghadimi’s team will help you explore coverage options during your first appointment.
Where do I get lab work done in Florida?
NuGen Medicine orders lab work through Quest Diagnostics and LabCorp, both of which have locations throughout Florida. We send orders to the lab location most convenient for you, and results are reviewed directly by Dr. Ghadimi before your next appointment.
How long do I need to stay on weight loss medication?
Treatment duration varies by patient. Most programs run 12 to 18 months, with Dr. Ghadimi evaluating your progress at regular intervals. Some patients transition to maintenance protocols after reaching their weight goals, while others may continue treatment longer based on medical need.
What side effects should I expect from GLP-1 medications?
The most common side effects include nausea, reduced appetite, and mild gastrointestinal discomfort, particularly during the initial dose escalation phase. Dr. Ghadimi manages these by starting at the lowest dose and increasing gradually. Most side effects diminish within the first few weeks of treatment.
Can I combine weight loss medication with other services at NuGen Medicine?
Yes. Many Florida patients receive coordinated care that includes medical weight loss alongside hormone replacement therapy, chronic disease management, or functional medicine. Dr. Ghadimi manages all services under one integrated treatment plan.